Veterinary Medicines

Parvoruvac Injektionssuspension für Schweine

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
  • Porcine parvovirus, strain K22, Inactivated
Download as PDF

Product identification

Medicine name:
Parvoruvac Injektionssuspension für Schweine
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
  • Porcine parvovirus, strain K22, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
    1.00
    Protective Dose
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain K22, Inactivated
    2.00
    log10 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 490a/87
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/08/2025
Download